HOW MUCH IS ENOUGH?

There’s probably a number most reps have in their head. $150K. $200K. Maybe $300K. The number where you think, if I could consistently make that, I’d be pretty happy.

But the more responses we get to the anonymous compensation survey, the more I’m realizing it’s not quite that simple.

We now have reps reporting W-2 compensation everywhere from under $75K to more than $400K. As you’d expect, the higher earners are generally more satisfied with their compensation. But not all of them.

We have reps making $300K+ who still don’t think they’re fairly compensated. We also have reps making considerably less who say they are.

So maybe the better question isn’t just how much you make.

What actually makes a medical device sales job worth it?

Let’s get into it.

We’re now at 59 anonymous submissions to the Med Device Compensation Index. It’s still a relatively small sample, and I’m definitely not ready to call any of this an industry benchmark. But we’re starting to have enough data to look beyond the W-2.

Of the 56 respondents who answered whether they believe they’re fairly compensated:

27 said yes.
18 said no.
11 weren’t sure.

So less than half currently believe they’re being paid fairly for their performance and responsibilities.

Now look at the $300K+ group. Of those who answered the same question:

14 said yes.
2 said no.
3 weren’t sure.

That means roughly 74% of the $300K+ respondents believe they’re fairly compensated. For everyone below $300K, that number drops to about 35%.

So yes, money matters. No surprise there.

But I’m more interested in the people making $300K+ who still answered no or weren’t sure. At first glance, it’s easy to think: How can someone making that much possibly feel underpaid?

But without knowing what they’re responsible for, the W-2 only tells us so much. If you’re managing a massive territory, growing revenue 20%, taking on more accounts and consistently beating quota, $300K might be great money and still not represent your fair share of what you’re producing.

That’s an important distinction.

“Do I make a lot of money?” and “Am I fairly compensated for what I produce?” aren’t necessarily the same question.

And I think that’s something worth tracking as this dataset grows.

There’s a weird career problem that comes with being successful in medical device sales. The better your territory gets, the harder it can be to walk away from it.

You spend years building surgeon relationships. You know every account, the OR staff, which facilities are growing, where the competitive business is and which surgeons might be willing to switch. Eventually, the territory starts producing and your income becomes pretty predictable.

Then another company calls. Better title. Higher base. Maybe equity. And a bigger OTE.

Now you have a decision to make.

The mistake, in my opinion, is comparing your current W-2 directly to the new OTE. If you’re consistently making $250K in an established territory, a new role offering a $300K OTE isn’t automatically a $50K raise.

One number is real. The other is a projection.

Before leaving a good territory, I’d want to know:

What has the new territory actually produced?

How much business already exists?

What did the previous rep make?

Why did they leave?

What percentage of the team actually hits OTE?

How long is the realistic ramp?

And most importantly, how much more upside am I getting for taking on all of that risk?

There are obviously plenty of good reasons to leave. Maybe the comp plan keeps getting worse. Maybe quota has become unrealistic. Maybe there’s nowhere left to move within the company. Maybe leadership is making your life miserable. Or maybe the new opportunity has a much higher ceiling and equity that could actually be worth something.

But I’d have a hard time leaving a $250K territory I know inside and out for a $300K OTE I know almost nothing about.

In this industry, an established territory has real value. So do the relationships you spent years building. I think reps should factor that into career decisions a lot more than we do.

We talked last week about more procedures moving into ambulatory surgery centers. There’s another part of that shift I think is worth paying attention to: what happens to the rep covering all of it?

A strong orthopedic territory used to be relatively concentrated in a handful of hospitals. That’s changing. The same surgeon might operate at the hospital one day and an ASC the next.

The procedure may be almost identical. From the rep side, it can be a completely different account. Different administrator, purchasing process, inventory, pricing, contracts and potentially a completely different person getting credit for the revenue.

As more volume moves into ASCs, a territory could grow while also becoming more difficult to cover. More facilities. More inventory moving around. More people to know. More credentialing. More places you need to be.

A $5M territory concentrated in two facilities is a very different job from a $5M territory spread across fifteen. The revenue might look identical on a spreadsheet. The workload definitely isn’t.

I don’t think that makes the ASC shift bad for reps. There’s a ton of opportunity there, especially for companies that figure out how to support these facilities efficiently. But it does make me wonder whether territory design and compensation will eventually have to change with it.

If the same amount of revenue requires significantly more coverage, should the economics of the territory stay the same?

I’m not sure they should.

One anonymous respondent recently described their biggest frustrations this way:

“Quota, work life balance, unacceptable growth expectations, lots of demand from hospitals with no clinical support to help, understaffed.”

I think a lot of reps will read that and know exactly what they mean. And it gets back to the question at the beginning of this issue: How much is enough?

Maybe there isn’t one number.

Someone making $200K with a manageable territory, good support and a realistic quota might feel much better about their situation than someone making $300K while constantly covering cases, fighting an impossible number and doing the work of two people.

The W-2 matters. Of course it does. But so does what you have to do to earn it.

Territory size matters. Hours matter. Support matters. Quota matters. Stress matters. And whether you can actually have a life outside of the job matters too.

That’s harder to capture in a compensation survey, but I think it’s just as important.

The best medical device job probably isn’t the one with the biggest W-2. It’s the one where the money, expectations and lifestyle actually make sense together.

As the Compensation Index grows, we’re getting closer to being able to answer some much more interesting questions.

Which specialties actually have the highest earning ceiling?

How does compensation change with experience?

Which comp structures produce the most satisfied reps?

At what income level does compensation satisfaction really start to change?

And eventually: Which companies offer the best combination of compensation, opportunity and rep satisfaction?

That last one could get interesting.

But I’m not interested in ranking companies based on two or three responses. We need a much larger sample before those comparisons mean anything.

That’s where we’re trying to get.

We’re currently at 59 anonymous submissions. The first major goal is 100.

Every response makes the comparisons more useful across specialty, role, experience, geography and compensation structure.

If you’ve already contributed, thank you. If you haven’t, it takes about three minutes and remains anonymous.

CONTRIBUTE TO THE COMPENSATION INDEX

And if you know another rep who would find this useful, forward it to them.

The goal isn’t just to figure out who makes the most money. It’s to give reps better information about what their experience, performance and responsibilities are actually worth.

And if there’s something happening inside medical device sales that nobody seems to talk about honestly, reply to this email.

I read every response.

The Med Device Rep
TheMedDeviceRep.com